Recently, a study found that the expression level of PARP-1 mRNA in glioma cell lines was significantly increased, suggesting that PARP-1 is expected to become a new prognostic indicator for glioma patients and a new anti-glioma therapy target (Han et al., 2020). Here, PARP1 is linked to central nervous system cancer.